232 related articles for article (PubMed ID: 38007992)
1. Mechanisms of multi-omics and network pharmacology to explain traditional chinese medicine for vascular cognitive impairment: A narrative review.
Lv S; Wang Q; Zhang X; Ning F; Liu W; Cui M; Xu Y
Phytomedicine; 2024 Jan; 123():155231. PubMed ID: 38007992
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Exploring the target and molecular mechanism of Astragalus membranaceus in the treatment of vascular cognitive impairment based on network pharmacology and molecular docking.
Lin L; Chen W; Yao C; Wu L; Yan Q; Cai X; Zhu S; Lao Y; Zhang G; Lan X; Chen Y
Medicine (Baltimore); 2023 Mar; 102(12):e33063. PubMed ID: 36961195
[TBL] [Abstract][Full Text] [Related]
4. Chinese herbal medicine for vascular cognitive impairment in cerebral small vessel disease: A protocol for systematic review and meta-analysis of randomized controlled trials.
Zhang X; Liu X; Xia R; Li N; Liao X; Chen Z
Medicine (Baltimore); 2020 Oct; 99(40):e22455. PubMed ID: 33019432
[TBL] [Abstract][Full Text] [Related]
5. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association.
Gorelick PB; Scuteri A; Black SE; Decarli C; Greenberg SM; Iadecola C; Launer LJ; Laurent S; Lopez OL; Nyenhuis D; Petersen RC; Schneider JA; Tzourio C; Arnett DK; Bennett DA; Chui HC; Higashida RT; Lindquist R; Nilsson PM; Roman GC; Sellke FW; Seshadri S;
Stroke; 2011 Sep; 42(9):2672-713. PubMed ID: 21778438
[TBL] [Abstract][Full Text] [Related]
6. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
7. Shengyu Decoction treating vascular cognitive impairment by promoting AKT/HIF-1α/VEGF related cerebrovascular generation and ameliorating MAPK/NF-κB mediated neuroinflammation.
Fang C; Liu J; Feng M; Jia Z; Li Y; Dai Y; Zhu M; Huang B; Liu L; Wei Z; Wang X; Xiao H
J Ethnopharmacol; 2022 Oct; 296():115441. PubMed ID: 35700854
[TBL] [Abstract][Full Text] [Related]
8. Network topology and machine learning analyses reveal microstructural white matter changes underlying Chinese medicine Dengzhan Shengmai treatment on patients with vascular cognitive impairment.
Lu H; Zhang J; Liang Y; Qiao Y; Yang C; He X; Wang W; Zhao S; Wei D; Li H; Cheng W; Zhang Z
Pharmacol Res; 2020 Jun; 156():104773. PubMed ID: 32244028
[TBL] [Abstract][Full Text] [Related]
9. Integration strategy of network pharmacology in Traditional Chinese Medicine: a narrative review.
Jiashuo WU; Fangqing Z; Zhuangzhuang LI; Weiyi J; Yue S
J Tradit Chin Med; 2022 Jun; 42(3):479-486. PubMed ID: 35610020
[TBL] [Abstract][Full Text] [Related]
10. [Research and development practice of traditional Chinese medicine based on network target theory and technology].
Li S; Wang BY; Cao L; Xiao LH; Chen P; Zhang B; Zhang XZ; Xiao W
Zhongguo Zhong Yao Za Zhi; 2023 Nov; 48(22):5965-5976. PubMed ID: 38114202
[TBL] [Abstract][Full Text] [Related]
11. Network pharmacology provides a systematic approach to understanding the treatment of ischemic heart diseases with traditional Chinese medicine.
Yang HY; Liu ML; Luo P; Yao XS; Zhou H
Phytomedicine; 2022 Sep; 104():154268. PubMed ID: 35777118
[TBL] [Abstract][Full Text] [Related]
12. Advances in anti hepatic fibrotic therapy with Traditional Chinese Medicine herbal formula.
Li H
J Ethnopharmacol; 2020 Apr; 251():112442. PubMed ID: 31891799
[TBL] [Abstract][Full Text] [Related]
13. [Research progress of traditional Chinese medicine intervention vascular cognitive impairment].
Cai YY; Jiang WM
Zhongguo Zhong Yao Za Zhi; 2017 May; 42(10):1837-1841. PubMed ID: 29090539
[TBL] [Abstract][Full Text] [Related]
14. Prospects for the application of traditional Chinese medicine network pharmacology in food science research.
Su Y; Bai Q; Tao H; Xu B
J Sci Food Agric; 2023 Aug; 103(11):5183-5200. PubMed ID: 36882903
[TBL] [Abstract][Full Text] [Related]
15. A serum metabolomics study of vascular cognitive impairment patients based on Traditional Chinese medicine syndrome differentiation.
Liu L; Qi YF; Wang M; Chen BX; Zhou QB; Tong WX; Zhang Y
Front Mol Biosci; 2023; 10():1305439. PubMed ID: 38116379
[No Abstract] [Full Text] [Related]
16. The treatment of rheumatoid arthritis using Chinese medicinal plants: From pharmacology to potential molecular mechanisms.
Lü S; Wang Q; Li G; Sun S; Guo Y; Kuang H
J Ethnopharmacol; 2015 Dec; 176():177-206. PubMed ID: 26471289
[TBL] [Abstract][Full Text] [Related]
17. Exploration of the mechanism of traditional Chinese medicine by AI approach using unsupervised machine learning for cellular functional similarity of compounds in heterogeneous networks, XiaoErFuPi granules as an example.
Guo F; Tang X; Zhang W; Wei J; Tang S; Wu H; Yang H
Pharmacol Res; 2020 Oct; 160():105077. PubMed ID: 32687952
[TBL] [Abstract][Full Text] [Related]
18. Multi-omics approaches for in-depth understanding of therapeutic mechanism for Traditional Chinese Medicine.
Zhu X; Yao Q; Yang P; Zhao D; Yang R; Bai H; Ning K
Front Pharmacol; 2022; 13():1031051. PubMed ID: 36506559
[TBL] [Abstract][Full Text] [Related]
19. Traditional Chinese medicine network pharmacology: theory, methodology and application.
Li S; Zhang B
Chin J Nat Med; 2013 Mar; 11(2):110-20. PubMed ID: 23787177
[TBL] [Abstract][Full Text] [Related]
20. Potential effect of Maxing Shigan decoction against coronavirus disease 2019 (COVID-19) revealed by network pharmacology and experimental verification.
Li Y; Chu F; Li P; Johnson N; Li T; Wang Y; An R; Wu D; Chen J; Su Z; Gu X; Ding X
J Ethnopharmacol; 2021 May; 271():113854. PubMed ID: 33513419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
